Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 199

Sort by

Sort Order Select

Journal Articles

TCA cycle mode switch determines the fate of pirtobrutinib-tolerant persister cells in mantle cell lymphoma

Blood (2025) 146 (21): 2544–2560.

https://doi.org/10.1182/blood.2024026919

Published: 2025

Includes: Supplemental data

Journal Articles

Enhancing the expansion of Naïve, potent T-cells via BTK inhibition reinvigorates CD19-CAR T-cell immunity and boosts antitumor efficacy in relapsed Mantle Cell Lymphoma

Yixin Yao, Yue Fei, Xiaolin Li, Joseph McIntosh, Yang Liu, Michael Wang

Blood (2025) 146 (Supplement 1): 1785.

https://doi.org/10.1182/blood-2025-1785

Published: 2025

Journal Articles

Efficacy and safety of zanubrutinib, rituximab, and venetoclax combination regimen in previously untreated follicular lymphoma: A Phase II trial from the bbc study

Chunmeng Wang, Zhengyuan Han, Jinhong Shi, Zhifang Li, Qingming Yang, Weidong Han, Yang Liu

Blood (2025) 146 (Supplement 1): 7108.

https://doi.org/10.1182/blood-2025-7108

Published: 2025

Journal Articles

Comparison of lentiviral promoters on the therapeutic efficacy of tri-specific CAR-T cells targeting CD19/CD20/CD22

Yang Liu, Borwyn Wang, Jessica Morris, Olivia Wise-Dent, Yanping Xie, Gregory Sowd, JiHyun Kim, Xiaorong Wu, Maggie Yates, Beatrix Ferencz, Ibeawuchi Oparaocha, Oxana Slessareva, Zhongyu Zhu, Boro Dropulic, Ying Xiong

Blood (2025) 146 (Supplement 1): 7706.

https://doi.org/10.1182/blood-2025-7706

Published: 2025

Journal Articles

The dynamic landscape of immune environment for MM patients receiving T cell redirectiing therapies

Haimeng Li, Xuelin Dou, Yang Liu, Guang Hu, Xiao-Dong Mo, Nan Peng, Lei Wen, Qian Li, Yue Wu, HuiXia Guo, Yijuan Chen, Liru Wang, Luyang Sun, Jin Lu

Blood (2025) 146 (Supplement 1): 7533.

https://doi.org/10.1182/blood-2025-7533

Published: 2025

Journal Articles

Dissecting pirtobrutinib resistance in Mantle Cell Lymphoma through single-cell multi-omics

Fangfang Yan, Yang Liu, Heng-Huan Lee, Wei Wang, Joseph McIntosh, Yijing Li, Jovanny Vargas, Yue Fei, Lukas Simon, Michael Wang

Blood (2025) 146 (Supplement 1): 1765.

https://doi.org/10.1182/blood-2025-1765

Published: 2025

Journal Articles

Artificial intelligence predicts genetic network disruptions to overcome CAR-T resistance in Mantle Cell Lymphoma

Fangfang Yan, Yang Liu, Heng-Huan Lee, Han Liang, Lukas Simon, Michael Wang

Blood (2025) 146 (Supplement 1): 1764.

https://doi.org/10.1182/blood-2025-1764

Published: 2025

Journal Articles

Clinical outcomes associated with serological subsets of heparin-induced thrombocytopenia

Ali Eshaghpour, Ishac Nazy, Sarah Kwok, Michael Hack, Yang Liu, Rumi Clare, John Kelton, Donald Arnold

Blood (2025) 146 (Supplement 1): 852.

https://doi.org/10.1182/blood-2025-852

Published: 2025

Journal Articles

Efficacy and safety of aponermin-carfilzomib-dexamethasone-based regimens for relapsed/refractory multiple myeloma: A Phase 2 prospective multi-center study

Huixing Zhou, Chunrui Li, Baijun Fang, Lingzhi Yan, Aijun Liu, Peiling Zhang, Yang Liu, Xiaoqi Qin, Huanxin Zhang, Wei Zhou, Hong-Hu Zhu, Leng Yun, Yin WU, Yi Wang, Wenming Chen, Guangzhong Yang

Blood (2025) 146 (Supplement 1): 2271.

https://doi.org/10.1182/blood-2025-2271

Published: 2025

Journal Articles

Safety and efficacy of aponermin-based chemotherapy as bridging therapy before CAR-T cell treatment in relapsed/refractory multiple myeloma

Huanxin Zhang, Yi Wang, Chengcheng Fu, Yanli Feng, Yang Liu, Jing Wang, Chunrui Li, Wenming Chen, Zhenyu Li

Blood (2025) 146 (Supplement 1): 2270.

https://doi.org/10.1182/blood-2025-2270

Published: 2025

Journal Articles

The switch of TCA cycle mode determines the fate of pirtobrutinib-tolerant persister cells

Michael Wang, Yang Liu, Qingsong Cai, Lei Nie, Heng-Huan Lee, Fangfang Yan, Yue Fei, Yijing Li, Lin Tan, Philip Lorenzi, Cheng-Tai Yu, Wei Wang

Blood (2025) 146 (Supplement 1): 330.

https://doi.org/10.1182/blood-2025-330

Published: 2025

Journal Articles

Early dflc response for predicting complete hematological response in patients with AL amyloidosis: A multi-center prospective observational study

Yang Liu, Xianghuang Huang, Huasheng Liu, Liru Wang, Yanqiu Zhao, Yini Wang, Yuping Zhong, Aijun Liao, Aili Zhai, Jinzhou Guo, Huinan Jiang, Xiaojun Huang, Jin Lu

Blood (2025) 146 (Supplement 1): 7496.

https://doi.org/10.1182/blood-2025-7496

Published: 2025

Journal Articles

Association between extreme heat exposures and survival in patients with multiple myeloma

Thomas Kuczmarski, Qingyang Zhu, Yang Liu, Philip Stevenson, Omar Nadeem, Jeremy Hess, Leticia Nogueira, Andrew Hantel

Blood (2025) 146 (Supplement 1): 2786.

https://doi.org/10.1182/blood-2025-2786

Published: 2025

Journal Articles

First-in-class dual BTK-MALT1 fusion inhibitors for treating resistant Mantle Cell Lymphoma

Vivian Jiang, Mingxiang Zhou, Hong Kim, Lei Nie, Qingsong Cai, Tianci Zhang, Chengtai Yu, Joseph McIntosh, Jun Yao, Jovanny Vargas, Yang Liu, Haiying Chen, Jia Zhou, Michael Wang

Blood (2025) 146 (Supplement 1): 390.

https://doi.org/10.1182/blood-2025-390

Published: 2025

Journal Articles

Efficacy and safety of CAV (cladribine, cytarabine and venetoclax) regimen in patients with newly diagnosed Acute Myeloid Leukemia

Jinghua Liu, Jianfang Wang, Minyan Li, Huanming Xu, Shuanglian Wang, Yang Liu, Meiyu Zhang, Danjiang Tong, Guanghan Meng, Junpeng Zhang, Jigang Wang, Fan Zhou, Jing Shen

Blood (2025) 146 (Supplement 1): 6955.

https://doi.org/10.1182/blood-2025-6955

Published: 2025

Journal Articles

BGB-3111-218: Single-arm, open-label, multicenter study of the Bruton tyrosine kinase (BTK) inhibitor zanubrutinib (zanu) in patients with CD79B-mutated Relapsed/Refractory (R/R) diffuse large B-cell lymphoma (DLBCL)

Blood (2025) 146 (Supplement 1): 3684.

https://doi.org/10.1182/blood-2025-3684

Published: 2025

Journal Articles

Synergistic effect of HLA evolutionary divergence and post-transplant biomarkers on non-relapse mortality prediction in adult haploidentical hematopoietic stem cell transplantation

Liping Dou, Di Guan, Yang-Liu Shao, Xiaobo Li, Ziqi Wang, Jingbo Wang, Yimei Feng, Xi Zhang, Xiangjun Liu, Daihong Liu

Blood (2025) 146 (Supplement 1): 2474.

https://doi.org/10.1182/blood-2025-2474

Published: 2025

Journal Articles

The Race Against Time: Rapid Dflc Response in C1D7 Predicts Complete Hematologic Response in Systemic AL Amyloidosis

Yang Liu, Jingyi Bi, Ashley Mai, Nan Peng, Lei Wen, KaiYan Liu, Jin Lu

Blood (2024) 144 (Supplement 1): 6878.

https://doi.org/10.1182/blood-2024-203345

Published: 2024

Journal Articles

A Pragmatic Monitoring Model for Non-Relapse Mortality Risk Based on Machine Learning in Patients Undergoing Allogeneic Hematopoietic Stem-Cell Transplantation

Yang-Liu Shao, Jingjing Yang, Xiaobo Li, Di Guan, Xiawei Zhang, Wu Tong, Zeliang Song, Dao Wang, Zhijie Wei, Jingbo Wang, Xiangjun Liu, Yuelin He, Liping Dou, Daihong Liu

Blood (2024) 144 (Supplement 1): 3573.

https://doi.org/10.1182/blood-2024-203190

Published: 2024

Journal Articles

Acalabrutinib with Rituximab Is Highly Effective First Line Treatment for Older Patients with Mantle Cell Lymphoma

Blood (2024) 144 (Supplement 1): 3038.

https://doi.org/10.1182/blood-2024-206042

Published: 2024

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

TCA cycle mode switch determines the fate of pirtobrutinib-tolerant persister cells in mantle cell lymphoma

Enhancing the expansion of Naïve, potent T-cells via BTK inhibition reinvigorates CD19-CAR T-cell immunity and boosts antitumor efficacy in relapsed Mantle Cell Lymphoma

Efficacy and safety of zanubrutinib, rituximab, and venetoclax combination regimen in previously untreated follicular lymphoma: A Phase II trial from the bbc study

Comparison of lentiviral promoters on the therapeutic efficacy of tri-specific CAR-T cells targeting CD19/CD20/CD22

The dynamic landscape of immune environment for MM patients receiving T cell redirectiing therapies

Dissecting pirtobrutinib resistance in Mantle Cell Lymphoma through single-cell multi-omics

Artificial intelligence predicts genetic network disruptions to overcome CAR-T resistance in Mantle Cell Lymphoma

Clinical outcomes associated with serological subsets of heparin-induced thrombocytopenia

Efficacy and safety of aponermin-carfilzomib-dexamethasone-based regimens for relapsed/refractory multiple myeloma: A Phase 2 prospective multi-center study

Safety and efficacy of aponermin-based chemotherapy as bridging therapy before CAR-T cell treatment in relapsed/refractory multiple myeloma

The switch of TCA cycle mode determines the fate of pirtobrutinib-tolerant persister cells

Early dflc response for predicting complete hematological response in patients with AL amyloidosis: A multi-center prospective observational study

Association between extreme heat exposures and survival in patients with multiple myeloma

First-in-class dual BTK-MALT1 fusion inhibitors for treating resistant Mantle Cell Lymphoma

Efficacy and safety of CAV (cladribine, cytarabine and venetoclax) regimen in patients with newly diagnosed Acute Myeloid Leukemia

BGB-3111-218: Single-arm, open-label, multicenter study of the Bruton tyrosine kinase (BTK) inhibitor zanubrutinib (zanu) in patients with CD79B-mutated Relapsed/Refractory (R/R) diffuse large B-cell lymphoma (DLBCL)

Synergistic effect of HLA evolutionary divergence and post-transplant biomarkers on non-relapse mortality prediction in adult haploidentical hematopoietic stem cell transplantation

The Race Against Time: Rapid Dflc Response in C1D7 Predicts Complete Hematologic Response in Systemic AL Amyloidosis

A Pragmatic Monitoring Model for Non-Relapse Mortality Risk Based on Machine Learning in Patients Undergoing Allogeneic Hematopoietic Stem-Cell Transplantation

Acalabrutinib with Rituximab Is Highly Effective First Line Treatment for Older Patients with Mantle Cell Lymphoma

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only